Diziderm N Cream contains Neomycin 0.5% w/w, an aminoglycoside antibiotic that inhibits bacterial protein synthesis, effectively controlling a wide range of Gram-positive and Gram-negative bacteria on the skin. Its topical application ensures localized antibacterial activity with minimal systemic absorption.
Clinically, this cream is indicated for superficial bacterial infections such as impetigo, infected eczema, minor cuts, abrasions, and skin trauma. It is also used to prevent secondary bacterial infections in minor dermatological injuries.
The cream formulation ensures uniform application, rapid absorption, and sustained local activity, making it suitable for dermatology clinics, hospitals, general practice, and outpatient skin care management. Its easy-to-apply consistency improves patient compliance and treatment adherence.
Diziderm N Cream helps in reducing infection, controlling bacterial growth, relieving inflammation, and promoting faster healing of affected skin areas. With its established clinical efficacy and safety profile under supervised use, it remains a trusted topical antibacterial therapy for skin care.